Imunon, Inc. Other Nonoperating Expense
Imunon, Inc. (IMNN) reported Other Nonoperating Expense of $396.32 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2025-02-27
- Imunon, Inc. other nonoperating expense for the quarter ending 2011-12-31 was -$4.00.
- Imunon, Inc. other nonoperating expense for the quarter ending 2011-09-30 was -$42.15K.
- Imunon, Inc. other nonoperating expense for the quarter ending 2011-06-30 was $0.00, a 100.00% decline year-over-year.
- Imunon, Inc. other nonoperating expense for the quarter ending 2011-03-31 was $0.00.
- Imunon, Inc. other nonoperating expense for fiscal 2023 was $396.32K.
- Imunon, Inc. other nonoperating expense for fiscal 2011 was -$42.15K.
- Imunon, Inc. other nonoperating expense for fiscal 2010 was -$244.46K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $396.32K 10-K · filed 2025-02-27 | |||
| 2011-12-31 | -$4.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | -$42.15K derived: sum of 2 quarters · filed 2012-03-15 | -$42.15K derived: sum of 3 quarters · filed 2012-03-15 | -$42.15K 10-K · filed 2012-03-15 |
| 2011-09-30 | -$42.15K 10-Q · filed 2011-11-10 | -$42.15K derived: sum of 2 quarters · filed 2011-11-10 | -$42.15K 10-Q · filed 2011-11-10 | -$286.62K derived: sum of 4 quarters · filed 2012-03-15 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 | $0.00 10-Q · filed 2011-08-09 | -$244.48K derived: sum of 3 quarters · filed 2012-03-15 | -$244.48K derived: sum of 4 quarters · filed 2012-03-15 |
| 2011-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2012-03-15 | -$244.48K derived: sum of 2 quarters · filed 2012-03-15 | -$244.48K derived: sum of 3 quarters · filed 2012-03-15 | -$244.47K derived: sum of 4 quarters · filed 2012-03-15 |
| 2010-12-31 | -$244.48K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | -$244.48K derived: sum of 2 quarters · filed 2012-03-15 | -$244.47K derived: sum of 3 quarters · filed 2012-03-15 | -$244.46K 10-K · filed 2012-03-15 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-10 | $5.00 derived: sum of 2 quarters · filed 2011-11-10 | $19.00 10-Q · filed 2011-11-10 | |
| 2010-06-30 | $5.00 10-Q · filed 2011-08-09 | $19.00 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |